Davidson Capital Management Inc. Abiomed Inc Transaction History

Davidson Capital Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$242.49 - $301.46 $727 - $904	3 Added 37.5%	11 $3,000
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $620 - $752	2 Added 33.33%	8 $3,000
Q2 2021 Aug 10, 2021	SELL	$262.71 - $351.17 $930,256 - $1.24 Million	-3,541 Reduced 99.83%	6 $2,000
Q1 2021 May 10, 2021	BUY	$285.92 - $355.13 $192,424 - $239,002	673 Added 23.42%	3,547 $1.13 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $21,913 - $28,205	87 Added 3.12%	2,874 $932,000
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $254,964 - $316,683	-999 Reduced 26.39%	2,787 $772,000
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $29,552 - $53,731	209 Added 5.84%	3,786 $915,000
Q1 2020 May 14, 2020	BUY	$130.51 - $196.01 $224,868 - $337,725	1,723 Added 92.93%	3,577 $519,000
Q4 2019 Apr 21, 2020	BUY	$159.31 - $223.54 $295,360 - $414,443	1,854 New	1,854 $316,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.